Viewing Study NCT06571734


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2026-01-22 @ 6:56 AM
Study NCT ID: NCT06571734
Status: RECRUITING
Last Update Posted: 2025-07-16
First Post: 2024-08-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma
Sponsor: Northwestern University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module